Autopsy report · NCT02864784

Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Budget”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1
Sponsor: Amorphical Ltd.
Sponsor type: Industry
Conditions: Castrate Resistant Prostate Cancer With Bone Metastasis
Interventions: Amorphous calcium carbonate; Placebo
Participants: 0
Sites: 1
Countries: Israel

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.